These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12688391)

  • 41. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac production of C-type natriuretic peptide in heart failure.
    Del Ry S; Maltinti M; Piacenti M; Passino C; Emdin M; Giannessi D
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):397-9. PubMed ID: 16721200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure.
    Andreas S; Reiter H; Lüthje L; Delekat A; Grunewald RW; Hasenfuss G; Somers VK
    Circulation; 2004 Oct; 110(15):2157-62. PubMed ID: 15466632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    de Resende MM; Kriegel AJ; Greene AS
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor.
    Ogawa S; Takeuchi K; Mori T; Nako K; Ito S
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):477-9. PubMed ID: 16700881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study.
    Shibazaki K; Kimura K; Okada Y; Iguchi Y; Terasawa Y; Aoki J
    J Neurol Sci; 2009 Jun; 281(1-2):55-7. PubMed ID: 19321180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
    Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure].
    Li Y; Chen X; Liu H; Luo F; Li G
    Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(3):324-7. PubMed ID: 19445159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
    Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog.
    Guyonnet J; Elliott J; Kaltsatos V
    J Vet Pharmacol Ther; 2010 Jun; 33(3):260-7. PubMed ID: 20557443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of perindopril on aldosterone production in the failing human heart.
    Mizuno Y; Yasue H; Yoshimura M; Fujii H; Yamamoto N; Nakayama M; Harada E; Sakamoto T; Nakamura S; Ito T; Shimasaki Y; Ogawa H; Saito Y; Nakao K
    Am J Cardiol; 2002 May; 89(10):1197-200. PubMed ID: 12008175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One year temporal pattern of neurohumoral factors and natriuretic peptides compared with clinical variables in patients with dilated cardiomyopathy.
    Rolfo C; Bobbio M; Brossa C; Bisi G; Trevi GP
    Minerva Cardioangiol; 2002 Dec; 50(6):661-5. PubMed ID: 12473986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation.
    Ceremuzyński L; Budaj A; Michorowski B
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):417-21. PubMed ID: 6629545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcardiac extraction of circulating endothelin-1 across the failing heart.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Horie H; Sugimoto Y; Kinoshita M
    Am J Cardiol; 2000 Sep; 86(5):524-8. PubMed ID: 11009270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
    Tsutamoto T; Sakai H; Wada A; Ishikawa C; Ohno K; Fujii M; Yamamoto T; Takayama T; Dohke T; Horie M
    J Am Coll Cardiol; 2004 Dec; 44(11):2252-3. PubMed ID: 15582326
    [No Abstract]   [Full Text] [Related]  

  • 60. High plasma concentration of the atrial natriuretic peptide (ANP) with suppressed aldosterone secretion in congestive heart failure.
    Marumo F; Katoh Y; Kurosawa T; Takeda S; Kurokawa S; Sakamoto H; Kikawada R; Ando K; Ishigami T
    Am J Cardiol; 1988 Feb; 61(6):498. PubMed ID: 2963531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.